טוען...
Beyond PD-1 Immunotherapy in Malignant Melanoma
For many years, the standard therapy for malignant melanoma was based mainly on surgical resection. Unfortunately, this treatment is curative only in the early localized stage of this malignancy. The metastatic stage of malignant melanoma still remains a huge therapeutic challenge. Despite the many...
שמור ב:
| הוצא לאור ב: | Dermatol Ther (Heidelb) |
|---|---|
| Main Authors: | , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Springer Healthcare
2019
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6522569/ https://ncbi.nlm.nih.gov/pubmed/30927248 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13555-019-0292-3 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|